首页> 外文期刊>Virchows Archiv: an international journal of pathology >LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
【24h】

LAT1 expression in normal lung and in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

机译:LAT1在正常肺以及非典型腺瘤性增生和肺腺癌中的表达。

获取原文
获取原文并翻译 | 示例
           

摘要

No previous study has investigated neutral large amino acid transporter type 1 (LAT1) in normal lung cells, or in atypical adenomatous hyperplasia(s) (AAH) and nonmucinous bronchioloalveolar carcinoma(s) (NMBAC) of the lung. The authors examined: (1) the levels of LAT1 mRNA/glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in 41 normal lung tissues and 34 NMBAC using semiquantitative reverse transcription-polymerase chain reaction; (2) LAT1 mRNA and protein expressions in 35 normal lung tissues, 34 AAH (11 lesions were interpreted as low-grade AAH and 23 as high-grade AAH), and 43 NMBAC using in situ hybridization and immunohistochemistry; and (2) the association of the incidences of LAT1 mRNA and protein expressions with cell proliferation in these lesions. The level of LAT1 mRNA/GAPDH mRNA (1) tended to be higher in NMBAC (12.0+/-8.1) than in normal lung tissues (1.0+/-0.2), and (2) covered a much wider range (from 0 to 276) in NMBAC than in normal lung tissues (from 0 to 5.8), with six NMBAC having values higher than 7.0, while 5.8 was the highest value detected in normal lung tissues. In peripheral normal lung tissues, LAT1 mRNA and protein were detected in bronchial surface epithelial cells and alveolar macrophages (but not in nonciliated bronchiolar epithelial cells, or in alveolar type I or type II cells). In bronchial surface epithelial cells, LAT1 protein appeared to be of a nodular type, which was considered to be a nonfunctional protein pattern. The incidences of positive expressions for LAT1 mRNA and protein were 54.5 and 27.3% in low-grade AAH, 65.2 and 52.2% in high-grade AAH, and 65.1 and 79.1% in NMBAC, respectively. In the case of LAT1 protein expression, significant differences could be shown between total (low-grade plus high-grade) AAH and NMBAC, and between low-grade AAH and NMBAC. Thus, in terms of the incidence of LAT1 protein expression, high-grade AAH appeared intermediate between low-grade AAH and NMBAC. The Ki-67 labeling index (a cell proliferation score) was significantly higher in those AAH and NMBAC that were LTA1-protein-positive than in their LAT1-protein-negative counterparts. In conclusion, LAT1 expression may increase with the upregulation of metabolic activity and cell proliferation in high-grade AAH and NMBAC.
机译:以前没有研究在正常肺细胞或非典型腺瘤性增生(AAH)和非粘液性细支气管肺泡癌(NMBAC)中研究1型中性大氨基酸转运蛋白(LAT1)。作者检查:(1)使用半定量逆转录-聚合酶链反应在41例正常肺组织和34例NMBAC中LAT1 mRNA / 3-磷酸甘油醛脱氢酶(GAPDH)mRNA的水平; (2)采用原位杂交和免疫组化方法,在35例正常肺组织,34例AAH(11个病灶被解释为低级AAH,23例为高级AAH)和43例NMBAC中LAT1 mRNA和蛋白表达; (2)这些病变中LAT1 mRNA和蛋白表达的发生与细胞增殖的关系。 NMBAC中LAT1 mRNA / GAPDH mRNA的水平(1)倾向于高于正常肺组织(1.0 +/- 0.2)(1),并且(2)涵盖范围更广(从0到276)的NMBAC值高于正常肺组织(从0到5.8),其中六个NMBAC值高于7.0,而5.8是正常肺组织中检测到的最高值。在外周正常肺组织中,在支气管表面上皮细胞和肺泡巨噬细胞中检测到LAT1 mRNA和蛋白(但在非纤毛性细支气管上皮细胞或I型或II型肺泡细胞中未检测到)。在支气管表面上皮细胞中,LAT1蛋白似乎是结节型的,被认为是一种无功能的蛋白模式。 LAT1 mRNA和蛋白阳性表达的发生率在低级AAH中分别为54.5%和27.3%,在高级AAH中分别为65.2和52.2%,在NMBAC中分别为65.1和79.1%。在LAT1蛋白表达的情况下,总AAH和NMBAC(低级和高级)之间以及低级AAH和NMBAC之间可能显示出显着差异。因此,就LAT1蛋白表达的发生率而言,高级AAH出现在低级AAH和NMBAC之间。那些LTA1蛋白阳性的AAH和NMBAC的Ki-67标记指数(细胞增殖分数)显着高于LAT1蛋白阴性的AAH和NMBAC。总之,在高级AAH和NMBAC中,LAT1表达可能随着代谢活性和细胞增殖的上调而增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号